Drug Type Small molecule drug |
Synonyms FP 1770, FP1770 |
Target |
Action agonists |
Mechanism mGluRs agonists(Metabotropic glutamate receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Preclinical | France | - | |
Depressive Disorder, Major | Preclinical | France | - | |
Parkinson Disease | Preclinical | France | - | |
Schizophrenia | Preclinical | France | - | |
Substance-Related Disorders | Preclinical | France | - |